Treatment of Acute Pulmonary Blastomycosis During Pregnancy

Acute pulmonary blastomycosis diagnosed during pregnancy presents a distinct management challenge. The concurrent state of pregnancy directly constrains antifungal selection, as fetal safety must be weighed alongside effective treatment of the infection.

Standard oral antifungal options used outside of pregnancy are not appropriate here due to teratogenicity concerns, requiring a different therapeutic approach from the outset.

The recommended approach involves a specific class of intravenously administered lipid-based antifungal agent. A major class of antifungals routinely used for blastomycosis in non-pregnant patients is contraindicated throughout pregnancy.